Our research data
Here are some of our notable research data that we captured over the years.
Effectiveness
-
Strong
-
Notable
-
Minor
Supplement Category
SAMe
AiWO SAMe contains 400mg active S– Adenosyl L– Methionine. S- Adenosyl L-methionine is a sulfonium compound that is an intermediate in the metabolic pathway of methionine. It is found naturally in the body including the liver, joints, and brain.
-
Arthritis
+S– Adenosyl L– Methionine enhances mobility, movement, and promotes joint comfort.
Italian Double-blind Multicenter Study Comparing S-adenosylmethionine, Naproxen, And Placebo In The Treatment Of Degenerative Joint Disease
http://www.ncbi.nlm.nih.gov/pubmed/3318442
Comparative Clinical Trial Of S-adenosylmethionine Versus Nabumetone For The Treatment Of Knee Osteoarthritis: An 8-week, Multicenter, Randomized, Double-blind, Double-dummy, Phase IV Study In Korean Patients
http://www.ncbi.nlm.nih.gov/pubmed/20110025
S-adenosyl Methionine (SAMe) Versus Celecoxib For The Treatment Of Osteoarthritis Symptoms: A Double-blind Cross-over Trial. ISRCTN36233495
http://www.ncbi.nlm.nih.gov/pubmed/15102339
Safety And Efficacy Of S-adenosylmethionine (SAMe) For Osteoarthritis
http://www.ncbi.nlm.nih.gov/pubmed/12019049
-
Depression
+S– Adenosyl L– Methionine reduces depression and is involved in the synthesis of various neurotransmitters in the brain.
S-adenosyl Methionine (SAMe) Versus Escitalopram And Placebo In Major Depression RCT: Efficacy And Effects Of Histamine And Carnitine As Moderators Of Response
http://www.ncbi.nlm.nih.gov/pubmed/24856557
S-adenosyl Methionine (SAMe) Augmentation Of Serotonin Reuptake Inhibitors For Antidepressant Nonresponders With Major Depressive Disorder: A Double-blind, Randomized Clinical Trial
http://www.ncbi.nlm.nih.gov/pubmed/20595412
S-Adenosyl-Methionine Improves Depression In Patients With Parkinson's Disease In An Open-label Clinical Trial
http://www.ncbi.nlm.nih.gov/pubmed/11104210
-
Pain
+S– Adenosyl L– Methioninehelps in to reduce osteoarthritis pain.
Italian Double-blind Multicenter Study Comparing S-adenosylmethionine, Naproxen, And Placebo In The Treatment Of Degenerative Joint Disease
http://www.ncbi.nlm.nih.gov/pubmed/3318442
S-adenosyl Methionine (SAMe) Versus Celecoxib For The Treatment Of Osteoarthritis Symptoms: A Double-blind Cross-over Trial. ISRCTN36233495
http://www.ncbi.nlm.nih.gov/pubmed/15102339
-
Functionality in Elderly or Injured
+S– Adenosyl L– Methionine increases in functionality of elderly persons on joints.
Italian Double-blind Multicenter Study Comparing S-adenosylmethionine, Naproxen, And Placebo In The Treatment Of Degenerative Joint Disease
http://www.ncbi.nlm.nih.gov/pubmed/3318442
S-adenosyl Methionine (SAMe) Versus Celecoxib For The Treatment Of Osteoarthritis Symptoms: A Double-blind Cross-over Trial. ISRCTN36233495
http://www.ncbi.nlm.nih.gov/pubmed/15102339
Safety And Efficacy Of S-adenosylmethionine (SAMe) For Osteoarthritis
http://www.ncbi.nlm.nih.gov/pubmed/12019049
-
Cognition
+SAMe (S-AdenosylMethionine) has been shown to support mood, cognition and brain
Effects Of S-adenosylmethionine Augmentation Of Serotonin-reuptake Inhibitor Antidepressants On Cognitive Symptoms Of Major Depressive Disorder
http://www.ncbi.nlm.nih.gov/pubmed/21911258